Founded by Prof. Michael Donmall and Dr Andrew Jones, the company innovates on the technologies developed by the National Drug Evidence Centre (NDEC) at the University of Manchester.
Michael is dedicated to the effective communication of results of complex data analyses via graphical and visualisation tools to a specialist and non-specialist audience.
He is a member of the University Senate, University Ethics Committee, holds an honorary contract as Public Health Academic (Health Sciences) with Public Health England and is Fellow of the Faculty of Public Health.
Involved in epidemiological and drug misuse research for 30 years, Michael established the National Drug Evidence Centre (NDEC) at the University of Manchester. In the 1980s he was responsible for developing an assessment system now used across the whole of the U.K. and the model for the treatment demand indicator across all Europe. NDEC is the academic host for the National Drug and Alcohol Treatment Monitoring System and carries out epidemiological, evaluative and policy related research.
He is also acknowledged as an indicator expert with experience in ‘information for policy’, and has expertise in the evaluation of treatment interventions and development of outcome and effectiveness measures. Recent large scale research projects include DTORS – the National Drug Treatment Outcomes Research Project and Evaluation of the Drugs and Alcohol Recovery PbR Pilots Programme.
Additionally, Michael has been the UK Expert at the European Monitoring Centre on Drugs and Drug Addiction for 15 years and a member of the Advisory Council on the Misuse of Drugs for 12 years. He has also been an advisor to the United Nations and authored the UN Global Toolkit on the Reduction of Related Harm.
Andrew’s research focuses on drug misuse treatment and the treatment outcomes that are achieved within the English treatment system.
He manages the analysis of the National Drug Treatment Monitoring System – the national treatment surveillance mechanism – to produce publicly available National Statistics and analyses designed to support commissioner-level performance management. These are systematically provided in web format on a monthly and annual basis.
Recent projects include a re-assessment of the resource allocation formulae for drug and alcohol public health spending; an evaluation of Payment by Results as a commissioning model for treatment of drug misuse; and a longitudinal outcomes study of drug misuse treatment clients based on active follow-up of a nationally recruited treatment cohort.
He built up his own development companies to a market capitalisation of £8 million within two years before selling them.
Yousef also has general management experience at senior level in commercial organisations, the National Health Service and education. He ran his own management and scientific advisory business for several years, supporting the management teams of both start-up and growth enterprises.
At ViewIt he focuses on strategic business development, product/technology development, business/resource planning, sales and marketing, budget control and financing.